Four years ago, protein drug developer Zymogenetics in Seattle began developing a recombinant version of the blood-clotting protein thrombin. On 17 January, it received US marketing approval for ...

Use with GEL-FLOW NT: reconstitute Thrombin-JMI 5000 IU powder with 5mL sterile isotonic ... these may cross-react with human factor V and lead to its deficiency. Do not re-expose patients if ...